Human multiple synostoses syndrome (SYNS) is an autosomal dominant disorder characterized by multiple joint fusions. We previously identified a point mutation (S99N) in FGF9 that causes human SYNS3. However, the physiological function of FGF9 during joint development and comprehensive molecular portraits of SYNS3 remain elusive. Here, we report that mice harboring the S99N mutation in Fgf9 develop the curly tail phenotype and partially or fully fused caudal vertebrae and limb joints, which mimic the major phenotypes of SYNS3 patients. Further study reveals that the S99N mutation in Fgf9 disrupts joint interzone formation by affecting the chondrogenic differentiation of mesenchymal cells at the early stage of joint development. Consistently, the limb bud micromass culture (LBMMC) assay shows that Fgf9 inhibits mesenchymal cell differentiation into chondrocytes by downregulating the expression of Sox6 and Sox9. However, the mutant protein does not exhibit the same inhibitory effect. We also show that Fgf9 is required for normal expression of Gdf5 in the prospective elbow and knee joints through its activation of Gdf5 promoter activity. Signal transduction assays indicate that the S99N mutation diminishes FGF signaling in developmental limb joints. Finally, we demonstrate that the conformational change in FGF9 resulting from the S99N mutation disrupts FGF9/FGFR/heparin interaction, which impedes FGF signaling in developmental joints. Taken together, we conclude that the S99N mutation in Fgf9 causes SYNS3 via the disturbance of joint interzone formation. These results further implicate the crucial role of Fgf9 during embryonic joint development.
Introduction
Multiple synostoses syndrome (SYNS) is a rare autosomal dominant disorder characterized by joint fusions involving proximal interphalangeal, carpal-tarsal, humeroradial and cervical spine joints. Thus far, four genes associated with SYNS have been identified: NOG (MIM 602991), GDF5 (MIM 601146), FGF9 (MIM 600921) and GDF6 (MIM 601147), mutations in which cause SYNS1 (MIM 186500), SYNS2 (MIM 610017), SYNS3 (MIM 612961) and SYNS4, respectively (1) (2) (3) (4) . NOG encodes the secreted protein Noggin, which acts as an antagonist to the bone morphogenetic proteins (BMPs) and is essential for cartilage morphogenesis and joint formation (1) . NOG mutations cause SYNS1 as well as proximal symphalangism (SYM1 [MIM 185800]), tarsal-carpal coalition syndrome (TCC [MIM 186570]), stapes ankylosis with broad thumb and toes (MIM 184460) and brachydactyly type B2 (BDB2 [MIM 611377]). GDF5 and GDF6 are members of the BMP family. Mutations in GDF5 also cause human bone disorders including acromesomelic dysplasia Hunter-Thompson type (MIM 201250) , brachydactyly type C (MIM 113100), and chondrodysplasia grebe type (MIM 200700) . It has been shown that GDF5 plays an important role during joint formation in humans and mice (2, 5, 6) . More recently, it has been reported that a GDF6 mutation results in wrist and ankle deformities at birth and progressive conductive deafness after the age of 40 in SYNS4 patients (4) . FGF9 is one of the 23 members of the FGF family. It is well known that FGF9 plays significant roles in multiple biological processes, including the development of bone, lung, testis, angiogenesis, bone repair and others (7) (8) (9) (10) (11) . We previously identified a p.Ser99Asn (S99N) mutation in exon 2 of FGF9 that is responsible for the development of SYNS3, and we showed that this mutation attenuates FGF signal transduction, resulting in abnormal cell proliferation and differentiation (3) . However, the physiological function of FGF9, especially its role in joint development at the early stage, and comprehensive molecular portraits of SYNS3 remain elusive.
Joint development is a sequential process of cell proliferation, differentiation and programmed cell death. The development of synovial joints begins with the early specification of the presumptive joint position within the condensed mesenchymal anlage (joint specification) (12) . The mesenchymal cells in the specified presumptive joint space are prohibited from differentiating into chondrocytes and are flattened to form transverse stripes called the interzone. Joint cavitation initiates at the periphery of the interzone and spreads centrally, whereas the areas proximal and distal to the joint cavity are continuous with the perichondrium of the cartilage skeleton and form the articular cartilage coating the ends of the opposed bones (13) . The FGF signaling pathway is an important regulator of joint development that acts in parallel with BMPs and the Wnt/b-catenin signaling pathway (14) (15) (16) . Homozygous Fgfr2c C342Y mice display synostosis of the knee joint with a posterior bony bridge and fusion of the lower cervical and upper thoracic sternebrae as well as the sacral and caudal vertebrae. ColII-Fgfr 31ach mice exhibit segmentation defects in the sternum and fusion of phalangeal joints (14, 17) . A spontaneous mutation (A143T) in mouse Fgf9 leads to radiohumeral and tibiofemoral synostosis (18) . Together, these findings indicate that abnormal FGF signaling contributes to the pathogenesis of disturbed joint development and that Fgf9 is crucial for normal joint development.
To further evaluate the physiological function of FGF9, especially in the early stage of joint development, and to investigate the pathogenic mechanism by which FGF9 S99N causes SYNS3, we introduce the S99N mutation into the mouse Fgf9 locus to generate a SYNS3 mouse model. Through extensive analyses of the phenotype, specific gene expression and cell differentiation, we demonstrate that Fgf9 plays a critical role in interzone formation during joint development by regulating mesenchymal cell differentiation. In addition, molecular interaction and signal transduction assays indicate that the S99N mutation in Fgf9 impairs FGF signaling. Furthermore, molecular simulation reveals that FGF9 S99N impairs FGF signaling through a conformational change that increases affinity to heparin and binding competition between FGFR and heparin, resulting in diminished FGF9 signaling, which contributes to SYNS3 pathogenesis.
Results

Generation of the Fgf9 S99N knockin mouse model
The S99N mutation in exon 2 of Fgf9 was introduced to the corresponding locus of the mouse genome through regular homologous recombination (Supplementary Material, Fig. S1A ).
Correctly recombined ES cell clones were confirmed by genomic polymerase chain reaction (PCR) and by the sequencing of PCR products from the mutant (mt) allele (Supplementary Material, Fig. S1B ). To rule out the possibility that insertion of the PGKNeo cassette or the S99N mutation affected Fgf9 expression, we performed reverse transcription quantitative real-time PCR (RTqPCR) on total RNA extracted from ES cell clones and observed normal Fgf9 expression in recombined ES cells, although they harbored the S99N mutation in the Fgf9 locus (Supplementary Material, Fig. S1C ). Through regular ES cell microinjection and mouse breeding, we obtained mutant mice with three different genotypes, which were screened by PCR using mouse tail genomic DNA (Supplementary Material, Fig. S1D ). Again, the genetic modifications did not affect protein or mRNA levels of Fgf9 expression in newborn mice brain tissue (Supplementary Material, Fig. S1E and F).
The S99N mutation in Fgf9 causes a SYNS3-like phenotype in mice
Since SYNS3 caused by the FGF9 S99N mutation follows an autosomal dominant pattern of inheritance, we first focused on the phenotype of heterozygous mice. We found that the growth, body and long bone length of heterozygotes were not significantly different compared to their wild-type (wt) littermates (Supplementary Material, Fig. S2A and B). However, 58.3% (198/ 340) of 3-4 weeks old heterozygous mutant mice were observed with apparent curly tail phenotype (Fig. 1A ). This ratio of curly tail raised to 84.21% (16/19) in heterozygous as they grow to 10 months old. A fusion of vertebrae joints and malalignment of tailbone in Fgf9 wt/mt mice were clearly shown by X-ray images (Fig. 1B) . Histological analyses further revealed that the abnormal joints of caudate vertebrae in Fgf9 wt/mt mice had synostosis between adjacent vertebrae, and the intervertebral disk disappeared (Fig. 1C) . Following the detection of SYNS3 phenotypes and the observation of dyskinesia of elbow and/or knee joints in Fgf9 wt/mt mice, we assessed the limb joints of adult heterozygous mice. The affected Fgf9 wt/mt mice (5.5%) at the age of 3 months displayed partial or complete fusions of the elbow and knee joints as well as enhanced bone density (Fig. 1D ). Histological analysis further revealed that in the Fgf9 wt/mt mice, the articular surface of the femur and tibia were destructed and fused with an enhancement of ossification (Fig. 1E ). These observations indicate that mice harboring a heterozygous mutation of S99N in Fgf9 nearly reproduce the SYNS3 phenotypes (3), but with a lower penetrance. Moreover, we observed that 9% (30/340) of heterozygotes exhibited apparently abnormal tooth development, featuring overgrowth and non-alignment of incisor teeth (Supplementary Material, Fig. S2C ). No sex ratio difference was observed in heterozygotes (Supplementary Material, Fig. S2D ), and fertility was normal in both males and females.
To probe the role of Fgf9 S99N in joint formation more deeply, homozygous mutant mice were obtained through sib mating between heterozygotes. The Fgf9 mt/mt mice were typically born alive, although they exhibited severe dyskinesia, failed to suckle and ultimately died within 6 days ( Fig. 2A) . Meanwhile, whole skeleton staining showed severe malformation of multiple joints in Fgf9 mt/mt mice. Elbow and knee joints in Fgf9 mt/mt mice were fused and displayed excess bone and cartilage (Fig. 2B) . Joints of caudal vertebrae in Fgf9 mt/mt mice were fused on one side, accompanied with enhanced ossification in vertebrae, resulting in twisted tails (Fig. 2C) . Histological analyses further revealed that the elbow and knee joint regions in Fgf9 mt/mt mice were replaced by calcified bone and cartilage, respectively, (Fig. 2D) . The intervertebral discs of caudal vertebrae in Fgf9 mt/mt mice were partially generated, but most regions of vertebral joints were filled with excessive chondrocytes (Fig. 2E) Fig. S3A ). This result indicates that joint malformation appears during joint cavitation or at an earlier stage. During interzone formation, hematoxylin and eosin staining (H&E) on sections of E13.5 limbs showed that the interzone in the elbow and knee joints of Fgf9 mt/mt mice was absent and exhibited ectopic chondrocytes (Fig. 3A) . The two opposing growth plates in E13.5 and E16.5 joints formed normally, suggesting that the specification of joint position was normal, and the failure of joint formation may result from the abnormal of interzone. We detect the expression of joint marker genes, Gdf5, in E11.5, E12.5 and E13.5 limb with WISH. As a result, the Gdf5 expression is dramatically downregulated in the region of elbow and knee joints, in a dosage dependent manner of mutant allele amount (Fig. 3B ). This data indicates that the S99N mutation leads to the joint fusion through interrupting the interzone formation. During a joint formation, the interzone is the key structure of the developmental joint. Mesenchymal cells in the interzone are restricted to differentiate into chondrocytes (21) . Alcian blue staining on sections of E13.5 Fgf9 mt/mt mice forelimbs indicated that the interzone mesenchymal cells were replaced by chondrocytes (Fig. 3C ). To confirm this conclusion, the expression of Col2a1, a chondrogenic marker, was detected in E11.5 and E12.5 forelimbs with WISH. As expected, Fgf9 mt/mt mice limbs exhibited higher levels of Col2a1, especially in the region of the prospective joint of knee and elbow (Fig. 3D , Supplementary Material, S4A). Further, the expression of SOX9, an important chondrogenic transcriptional factor (22) , exhibited an expanded expression pattern in the junction of femur and tibia in E12.5 Fgf9 mt/mt mice (Fig. 3E ). In addition, the SOX9 expression pattern in E13.5 mice elbow of Fgf9 mt/mt mice was consistent with that in 
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. These data suggest that the failure of interzone formation, which might result from the abnormal differentiation status of mesenchymal cells, contributes to joint synostosis in Fgf9 mt/mt mice limbs.
Fgf9 inhibits mesenchymal cell differentiation into chondrocytes through the downregulation of Sox6 and Sox9
The undifferentiated status of mesenchymal cells in the interzone is crucial for the maintenance of structural stability (21) . The excess chondrogenesis in the interzone of Fgf9 mt/mt mice implied that Fgf9 was responsible for mesenchymal cell chondrogenic differentiation. To verify this assumption, we analyzed the chondrogenetic differentiation ability of mesenchymal cells from E11.5 limbs by LBMMC in-vitro, and found that the Fgf9 maintains Gdf5 expression in the elbow and knee joints during development
Gdf5 plays important roles in interzone formation and chondrocyte differentiation; thus, it is often used as a joint marker (6, 25) . In addition, mutation in GDF5 has been identified to be responsible for SYNS2 (2) . Therefore, the expression of Gdf5 was detected in developmental limbs at E11.5, E12.5 and E13.5. Interestingly, Gdf5 was significantly downregulated in the elbow and knee joint regions of Fgf9 mt/mt mice at E11.5, E12.5 and E13. the range of increase induced by Fgf9 S99N was significantly lower than that of Fgf9 WT (Fig. 5C ). These results suggest that Fgf9 is responsible for sustaining the expression level of Gdf5 during joint development by activating its promoter activity. It implies that there are underlying relationship between SYNS2 and SYNS3.
The S99N mutation on Fgf9 reduces signal transduction in joints
As described above, Fgf9 functions to downregulate the expression levels of Sox6 and Sox9 and to upregulate Gdf5 expression, whereas the S99N mutation attenuates these functions. These results suggest that the S99N mutation impairs FGF signaling during joint formation. FGF signaling is mediated by FGF receptors, and FGFR2 and FGFR3 are the main receptors of FGF9 (27) . First, we detected the expression of Fgf9, Fgfr2 and Fgfr3 in the limbs of E11.5 and E12.5 embryos with WISH, IF and RT-qPCR. The expression of Fgf9 located in the region of the myoblast and skin surrounding the bone cartilage ( Fig. 6A and B) , and its mRNA level was increased in Fgf9 mt/mt mice limbs (Fig. 6G ).
WISH and IF analysis data showed that the expression pattern of Fgfr2 is along with the cartilage, and highly expressed in the region of the joint ( Fig. 6C and D) . Fgfr3 was expressed in the cartilage anlage specifically (Fig. 6C) . Interestingly, Fgfr2 was expressed in the ventro-caudal vertebrae of E11.5 tail, with Fgfr3 expressed along with the dorso-caudal vertebrae (Supplementary Material, Fig. S6A ). It is reported that FGF9 acts as an autocrine and a paracrine role in different cells and tissues (7, 28, 29) . The expression pattern of Fgf9 and Fgfr2/3 imply that Fgf9 plays a paracrine signaling role during joint formation. It implied that Fgfr2 and Fgfr3 play distinct roles during joint development and Fgfr2 might play key roles during joint development. was used for detecting the expression levels of Sox6 (G) and Sox9 (H) by RT-qPCR (mean 6 SD). * P < 0.05; *** P < 0.001. Results above is a representative of at least two independent experiments.
Etv4, Etv5 and Spry2, which are known to be transcriptionally activated by FGF signaling (30, 31) , were also examined in the limb of E11.5 embryos. Etv5 was expressed in the region of developmental cartilage, and its expression level was downregulated in the limb of Fgf9 mt/mt mice, especially in the prospective regions of elbow and knee joints (Fig. 6E) . The expression pattern of Spry2 was similar to Fgf9, and its expression level was downregulated in the limb of Fgf9 mt/mt mice (Fig. 6F ). This observation was confirmed by the expression levels of Etv4, Etv5 and Spry2 in total RNA of E11.5 limbs (Fig. 6H-J) . With the reduction in FGF signaling in homozygotes, the expression level of Fgfr1-4 exhibited a compensatory increase in E11.5 limbs (Supplementary Material, Fig. S6B-E) .These data indicate that the S99N mutation in Fgf9 diminishes FGF signal transduction in developmental limbs, especially in the elbow and knee joint regions, leading to joint development failure.
The S99N mutation changes the conformational structure of FGF9, leading to a lower affinity to its receptors
The S99N mutation in FGF9 leads to attenuated FGF9 signal transduction without affecting secretion and dimerization (3), which drove us to explore the status of ligand/receptor interaction in Fgf9 mt/mt mice. FGF9 signal transduction is mediated by a ternary complex, FGF9-FGFR-heparan sulfate proteoglycan (HSPG) (32) , which dimerizes FGFR and transfers the signal to the intracellular domain of FGFR by autophosphorylation, followed by several pathways (33) . Thus, studying the interaction between FGF9, FGFR and HSPG may reveal the underlying mechanism by which the S99N mutation diminishes FGF9 signal transduction.
The affinity between FGF9 WT /FGF9 S99N and FGFR2/3 was assessed using an immunoprecipitation assay after cotransfection of Flag-Fgf9 and His-Myc-Fgfr2c/Fgfr3c in the HEK-293 cell line. FGF9 S99N had a lower affinity with both FGFR2IIIc
and FGFR3IIIc compared to FGF9 WT (Fig. 7B) , which may lead to reduced FGF9 signal transduction. On the other hand, HSPG plays important regulatory roles during FGF signaling, and impaired HSPG synthesis dramatically decreases FGF signaling (34) . The binding affinity between FGF9 and HSPG was assessed using heparin-sepharose bead pulldown with Fgf9-transfected Cos-7 cell culture supernatant washed with PBS containing a gradient concentration of NaCl. Residual FGF9 was detected by Western blot with an anti-FGF9 antibody. The expression levels of FGF9 WT and FGF9 S99N were equal in cell lysates and supernatants ( Fig. 7C and D) . At the physiological concentration of NaCl (0.15 M), FGF9 S99N had a similar affinity with heparin compared to FGF9
WT . However, FGF9 S99N had intense resistance upon increasing the concentration of NaCl (0.15-0.5 M), which decrease molecular affinity by enhancing ionic strength (Fig. 7E) . These results indicate that FGF9 S99N has higher affinity to heparin than FGF9
WT . For a deeper understanding of this phenomenon, we manipulated molecular simulation analyses using FGF9, FGFR3 and heparin. The reconstruction structure showed that in FGF9 WT , the FGFR3 and heparin binding domains were separate. However, FGF9 S99N exhibited an overlap between these two binding domains which would cause binding competition between the FGFR3 and heparin binding sites (Fig. 7A) . Thus, the higher affinity for heparin and binding competition between heparin and FGFR that result from the S99N mutation decrease the affinity between FGF9 S99N and FGFR, ultimately attenuating FGF9 signal transduction. (mean 6 SD). *P < 0.05, **P < 0.01, ***P < 0.001.
Discussion
The Fgf9 S99N mutant mice exhibited the major phenotypes similar to the SYNS3 patients, but there still exist some differences. The heterozygous mice display a lower penetrance (58.3%, curly tail) at the age of 3-4 weeks compared to human SYNS3 patients, with an autosomal dominant pattern of inheritance. And the penetrance in mouse model increased as the age grows. The ratio of curly tail raised to 84.21% in heterozygous as they grow to 10 months old, which is higher than the younger mice. Meanwhile, the curly tail phenotype in heterozygous mice turned out with diversity, such as the difference in fused causal vertebrae number and location, which might indicate that there could be the neglect of a mild phenotype in heterozygous mice. The low penetrance of heterozygotes might be caused by the limitation of the detection method and the difference susceptibility of the mutant gene between human and mouse. The phenotype variability in Fgf9 wt/mt mice might due to the expression level of wt and mutant allele. Highly expression level of mutant allele in Fgf9 wt/mt mice might result in severe phenotypes.
Fgf9 regulates joint interzone formation in a spatio-temporal manner. Joint development is a well-organized process that depends on cell proliferation, differentiation and apoptosis (13) . During this process, FGF signaling plays pivotal roles, and abnormal FGF signaling leads to failure of joint formation (14, 17, 18) . However, the mechanisms underlying the regulation of joint development by FGF signaling are still elusive. Our results indicate that Fgf9 is required for interzone formation at The mRNA levels of Fgf9, Etv4, Etv5 and Spry2 were detected with RT-qPCR in the limbs of E11.5 embryos, respectively (n ¼ 3, mean 6 SD). Scale bar ¼ 500 mm, *P < 0.05, **P < 0.01. The image showed above is a representative of at least two individuals. the early stage of joint development. The interzone is comprised of closely packed mesenchymal cells which are prohibited from differentiating into chondrocytes at the stage of interzone formation. The undifferentiated status of interzone mesenchymal cells is crucial for joint development (35) . We demonstrate that Fgf9 is able to inhibit mesenchymal cell differentiation into chondrocytes by downregulating the expression of the chondrogenic transcription factors Sox6 and Sox9. The S99N mutation results in impaired FGF signaling, which interferes with the inhibition of mesenchymal cell chondrogenesis and results in excess chondrogenesis in the interzone region. In particular, impaired FGF signaling and diminished Gdf5 expression specifically occur in the elbow and knee joints in Fgf9 mt/mt mice, while other joints are not affected. This expression pattern is consistent with the phenotype of mutant mice which suffer severe joint synostosis of the elbow and knee while the distal synovial joints of limbs are barely affected (Supplementary Material, Fig. S7A and B) . These results indicate that FGF9 enacts site-specific regulation of joint development and different joints may be regulated by distinct signaling pathways. This phenomenon may relate to the differing expression patterns of FGFRs and FGFs. We show that the expression of Fgf9 is surrounding the bone cartilage, whereas Fgfr2 is expressed in the mesenchymal cells of the prospective elbow joint and Fgfr3 is mainly expressed in cartilage (Fig. 6A-D) . Besides, it is reported that FGFR2 is highly expressed in the developing elbow joints and adjacent cartilage tissues of human embryos (36) . The specific expression pattern implies that Fgf9 regulates interzone formation in a spatio-temporal manner with transducing a paracrine signaling through Fgfr2. However, the precise regulation of the development of different joints is still elusive and needed to be investigated further. It also raises a question, which is how to regulate the formation of joints in different positions with specifically signaling. FGF9 may not only regulate the interzone development, but also regulates the skeletal development and homeostasis. We have shown that the joint synostoses are due to the failure of interzone development at the early developmental stage in Fgf9 mt/mt mice. However, the joint disorder in the Fgf9 wt/mt mice might not only be caused by the developmental disorder, but also a consequence of the skeletal development and homeostasis disorder. The penetrance of Fgf9 wt/mt mice shows the age dependency. The ratio of curly tail raised to 84.21% in heterozygous as they grow to 10 months old, which is higher than the younger mice (58.3%). The early development of curly tail was due to the caudal vertebral joints formation defects during embryogenesis. As the age increasing, the mild phenotype in heterozygous mice turns to be severe with calcification of the vertebrae and retrogradation of the vertebral discs. And we do not find the vertebral segmentation defects and neuromuscular dysfunction in heterozygous. Histological analysis data of the fused knee joint in the Fgf9 wt/mt mice reveal that the opposed surface does not disappear (Fig. 1E) , which indicated that the early development of joint is normal. It is also important to note that the fused or normal joints in Fgf9 mt/mt mice are always parallel with the ossification enhancement (Fig. 1D) . Besides, the newborn homozygous mice display increased bone width and early calcification of causal vertebrae. These results suggest that Fgf9 not only regulates the joint formation during embryogenesis, but also regulates the skeletal development, especially the osteogenesis. Previously studies have also demonstrated that Fgf9 plays important roles in bone development and osteogenesis (9, (37) (38) (39) (40) . S99N mutation in Fgf9 might affects the balance between osteogenesis and osteoclastogenesis by regulating the proliferation and differentiation of osteoblast and osteoclast, leading to enhanced osteogenesis. Thus, it implies that the S99N mutation on Fgf9 might affect the bone homeostasis, which still needs further investigation. The homeostatic regulation of FGF9 signaling is crucial for joint development. Previous work has discovered that the N143T mutation of FGF9 leads to disturbance of FGF9 dimerization and decreased heparin binding ability. These defects result in increased diffusion of FGF9
N143T , leading to ectopic FGF signaling and repression of joint development (18) . However, our study provides another view, in which impaired FGF9 signaling also contributes to the failure of joint development. The Ser99 of FGF9 is in the critical region required for HSPG binding. When Ser99 is replaced by Asn, the dimerization and secretion of FGF9 are unaffected (3), but FGF9 signal transduction in the developmental elbow and knee joint is attenuated. The FGF signaling readouts Etv4, Etv5 and Spry2 were down regulated in the developing elbow and knee joints of Fgf9 mt/mt mice. Because the promoter activity of Gdf5 is regulated by Fgf9, Gdf5 is nearly absent at the prospective joint region of the elbow and knee in Fgf9 mt/mt mice. Further, Fgf9 has an inhibitory effect on mesenchymal cell differentiation, whereas the S99N mutation diminishes this effect. Besides, we also observed some Fgf9 S6B-E). This hypothesis of general changes in FGF signaling disrupting joint development may explain why the skeleton disorders in Fgf9 S99N mice and Fgf9 EKS mice were more severe than those in Fgf9 -/-mice. Moreover, the property of mutation still needs to be clarified with more evidences. For instance, we could cross a S99N mutant mouse with Fgfr gain-of-function mutation mouse model, such as Fgfr3 G369C/þ mice, in order to observe that whether the gain-of-function mutation can reverse the phenotypes of S99N mutation. Multiple synostoses syndromes driven by different genetic mutations may share similar but hidden regulatory pathways. Thus far, four genes have been linked to the four independent SYNS, including NOG for SYNS1, GDF5 for SYNS2, FGF9 for SYNS3 and GDF6 for SYNS4. Different gene mutations cause different SYNS, but these disorders exhibit similar clinical manifestations, which suggests that they may have similar pathogenic mechanisms and share the same regulatory pathway. The NOG gene is an antagonist to BMPs that blocks the BMP type I (BMPRI) and type II (BMPRII, ActRII, ActRIIB) interaction sites on the ligand (45) . GDF5 and GDF6 belong to the BMP family, which is essential for cartilage, bone and joint formation. Gerburg K. Schwaerzer et al. reported that the S94N mutation of GDF5 lost noggin resistance, resulting in excess chondrogenesis during joint development (46) . The GDF6 Y444N mutation led to NOG-mediated antagonism resistance and increased chondrogenesis in the joint region, causing synostosis of multiple joints in SYNS4. These results suggest that SYNS1, SYNS2 and SYNS4 have similar pathogenic mechanisms; however, the relationship between SYNS3 and other SYNS is not known. Here, our studies demonstrate that Fgf9 can regulate the expression level of Gdf5 in the joint region. The expression level of Gdf5 was significantly decreased at the region of the elbow and knee joint in Fgf9 mt/mt mice, which is consistent with downregulation of FGF signaling. Further, Fgf9 upregulated Gdf5 promoter activity in vitro. The results of this study may provide important evidence for determining whether the different SYNS share the same regulatory pathway. Mutations of genes in these pathways may disturb the normal process of joint development and result in the joint synostoses syndrome. However, joint development is a complicated developmental process, and the relationship between different SYNS-driven genes will require careful investigation in the future.
In conclusion, we revealed that Fgf9 plays a significant role in interzone formation and that the S99N mutation contributes to the pathogenesis of SYNS3. This study advances our understanding of the biological function of Fgf9 during joint development and mesenchymal cell differentiation.
Materials and Methods
Ethics statement
All procedures involving animals were reviewed and approved by the Institutional Animal Care and Use Committee of Rui-Jin Hospital, School of Medicine, Shanghai Jiao Tong University (approval number: SYXK 2011-0113).
Generating a knock-in mouse model
A targeting vector containing a G to A mutation on exon 2 and a PGK-NEO fragment in intron 2 was constructed. The targeting construct was electroporated into ES cells. With a double selection of G418 and GANC, resistant clones were identified by PCR using 5' arm and 3' arm primers. Two correctly recombined ES cell clones were selected and used to create mutant mice through blastocyst microinjection. The Fgf9 wt/mt mice were generated through crossing chimeras with wt 129S1 mice. Offspring genotype was identified using PCR with 3 primers in one reaction, which amplified a 696 bp product for wt and a 487 bp product for the mutant allele. Fgf9 mt/mt mice were generated by sib-mating between heterozygous mutants. The mutation was verified by sequencing the PCR product from ES cell identification, genotyping and Fgf9 expression analysis. The expression level of Fgf9 was detected in ES cell and brain of newborn offspring by RT-qPCR and Western blot. Mice were bred in specific pathogen-free (SPF) conditions and maintained on the 129S1 background. All experiments were performed according to protocols approved by the Institutional Animal Care and Use Committee of Shanghai Jiao Tong University. Primers used are presented in Supplementary Material, Table S1 .
Radiologic imaging
3-month-old mice for radiologic analyses were anesthetized with 40 mg/kg napental. High-resolution bone X-rays were obtained using GE. Sino DS.
Skeletal staining and histological analyses
Skeletal staining was performed according to McLeod (1980) with minor modifications (47) . The limbs of the P0 mice were fixed for 48 h in ethanol and then for 48 h in acetone. Afterwards, bones were stained with a mixture of 0.3% Alcian blue, 0.1% alizarin red, glacial acetic acid and 70% ethanol (1:1:1:17) with constant rotation at room temperature for 3 days. Limbs were cleared in 1% KOH and taken through graded steps into 80% glycerol. Then, the skeletons were collected and stored in 100% glycerol. Tissues for histological analyses were harvested from E12.5, E13.5, E16.5 and P0 mice, fixed in 4% paraformaldehyde (PFA) and embedded in paraffin according to standard procedures. Samples were sectioned at 5 lm and stained with H&E. Skeletons from 3-month-old mice were fixed in 4% paraformaldehyde and decalcified with 12.5% EDTA-Na 2 for one month at 4 C. The samples were then processed as described above. Alcian blue and von Kossa staining on sections were manipulated as previously described (48) .
Whole mount in situ hybridization
WISH was performed as previously described (49) . Mouse limbs were collected from E11.5 to E13.5 embryos and fixed with 4% PFA overnight at 4 C. For storage, samples were dehydrated through gradient concentration of methanol and stored at À20 C. Embryo genotypes were identified by PCR. The digoxigenin-labeled RNA probes for Col2a1 (MGI: 88452), Etv5 (MGI: 1096867), Fgf9 (MGI: 104723), Fgfr2 (MGI: 95523), Fgfr3 (MGI: 95524), Gdf5 (MGI: 95688) and Spry2 (MGI: 1345138) were prepared using a DIG RNA labeling kit according to the manufacturer's protocol (Roche, Mannheim, Germany). Before hybridization, samples were rehydrated, digested with 10 lg/ml proteinase K for 30 min at room temperature and re-fixed in 4% PFA for 1 h at 4 C. Afterwards, specimens were pre-hybridized for 3 h at 68 C then hybridized with the probes overnight at 68 C. After hybridization and washing, the signal was detected by anti-digoxigenin alkaline phosphatase-conjugated Fab fragments (Roche) and visualized with the Vector NBT/BCIP Staining Kit as described (VECTOR).
Immunofluorescence assay
Briefly, samples were collected and fixed in 4% PFA at 4 C overnight then embedded into wax and sectioned into 5 mm slices. Sections were dewaxed and underwent microwave antigen retrieval in 0.01 M citrate sodium (pH 6.0, for SOX9 and FGF9) or 0.25% trypsin-EDTA treated antigen retrieval (for FGFR2). After washing, samples were blocked in 10% goat serum and incubated with anti-SOX9 (ab26414, 1:500), anti-FGF9 (ab9743, 1:100) and anti-FGFR2 (ab10648, 1:500) antibody at 4 C overnight.
Samples were then incubated with secondary antibody for 2 h at room temperature. Nuclei were stained with DAPI (Sigma) and mounted with mounting medium (DAKO). All images were captured under a fluorescence microscope (NIKON ECLIPSE 8Vi).
Promoter activity assay 
GST-FGF9 WT and GST-FGF9 S99N expression and purification
Wild-type and mutant Fgf9 were cloned into the pGEX 4T-1 GST expression vector. BL21(DE3) was chosen as a host bacterium to express the GST-FGF9 fusion protein with 10 lm isopropyl-b-Dthiogalactoside (IPTG) inducing for 6 h at 37 C. Cells were collected and lysed by ultrasonication in lysis buffer (10 mM DTT in PBS with protease inhibitor cocktail) at 130 W for 10 min with 10 s on/15s off per cycle on ice. Cell lysate was collected by centrifugation at 10,000 Â g for 15 min at 4 C. Afterwards, the supernatant was passed through a 2 ml GST-binding column (Novagen) and washed with 50 ml PBST (0.1 TritonX-100). Bound protein was eluted with 2 ml elution buffer (10 mM reduced glutathione in 50 mM Tris-HCl, pH 8.0). The eluted protein was concentrated with a 3 kDa centrifugal filter concentrator (Millipore, UFC500396), and the buffer was changed to PBS. Protein concentration was quantified using a BSA standard curve after separating in SDS-PAGE and staining with Coomassie brilliant blue.
Limb bud micromass culture and differentiation
The limbs from E11.5 embryos were collected in culture medium (DMEM þ 10% FBS) and incubate at 5% CO 2 , 37 C in a humidified tissue culture incubator, until the genotype was identified. Mouse limbs were digested (0.5% collagenase I, Sigma) and dispersed into single cell suspensions as previously described (50) . After counting, cells were collected and suspended in the appropriate volumes of culture medium (DMEM, 10% FBS, pep/strep) to a final concentration of 2 Â 10 7 cells/ml. The concentrated cell suspension was plated at 10 ll per well in a 24-well culture plate and incubated at 5% CO 2 , 37 C in a humidified tissue culture incubator for 2 h. After cells were attached, 1 ml of culture medium was added to feed the micromass. After 24 h, the medium was changed to differentiation medium containing 25 lg/ml ascorbic acid and gradient concentrations (20 ng/ml, 50 ng/ml, 100 ng/ml) of GST-GFP, GST-FGF9 
Molecular simulation
The crystal structures of the FGF9 and FGFR3c monomers were obtained from the Protein Data Bank (PDB) with PDB entries 1ihk.pdb and 1ry7.pdb, respectively. The wt monomer structure (1ihk.pdb) was used as a structure template for FGF9 S99N , which was constructed using the homology model procedure in Molecular Operating Environment ( 
mRNA and protein analyses
Total RNA was extracted from cells and tissues with Trizol reagent RNA extraction protocol according to the manual (Roche). cDNA was obtained by reverse transcription from 1 lg RNA. Gene expression levels were detected using RT-qPCR with RealPlex (Eppendorf). The primers used are presented in Supplementary Material, Table S1 . Actin was used as internal control. Protein was extracted from cells and tissues with NETN lysis buffer (100 mM NaCl, 20 mM Tris-HCl pH 8.0, 0.5 mM EDTA, 0.5% Nonidet P-40) with protease inhibitor cocktail (Roche). Protein was separated by SDS-PAGE and detected with the indicated primary antibody and fluorescent secondary antibody. The Western blot images were developed with Odyssey nearinfrared fluorescence imaging system (Li-COR). Each Western blot shown was a representative of a minimum of 3 independent experiments.
Statistical analysis
Results are presented as the mean 6 standard deviation (SD). The significant differences were analyzed with Student's t test. Statistical significance was assumed for P < 0.05.
Supplementary Material
Supplementary Material is available at HMG online.
